Skip to main navigation Skip to search Skip to main content

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia

  • Jung Eun Park
  • , Hiu Fung Yuen
  • , Jian Biao Zhou
  • , Abdul Qader O. Al-aidaroos
  • , Ke Guo
  • , Peter J. Valk
  • , Shu-Dong Zhang
  • , Wee Joo Chng
  • , Cheng William Hong
  • , Ken Mills
  • , Qi Zeng

Research output: Contribution to journalArticlepeer-review

66 Downloads (Pure)
Original languageEnglish
Pages (from-to)1351-1366
JournalEMBO Molecular Medicine
Volume5
Issue number9
DOIs
Publication statusPublished (in print/issue) - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • acute myeloid leukaemia
  • antibody therapy
  • FLT3-ITD mutation
  • PRL-3
  • prognostic marker

Cite this